Literature DB >> 19192324

Is it not time for health economists to rethink equity and access?

Gavin Mooney1.   

Abstract

This article considers two key issues in health economics regarding the question of equity. First, why have health economists not resolved better the issue of what are equity and access? Second, the paper draws attention to the relative lack of analyses of equity concerns outside of health care. The question of whose values should prevail in equity is also addressed. On the first issue, there is an obsession with quantification in economics with the result that in analysing equity, in practice often 'use' has been substituted for 'access'. The problem of defining access has thereby been by-passed. This has taken the pressure off trying to research access per se. Second, what is meant by equity and access are in part culturally determined. The continued efforts of health economists to treat equity as some universal construct are misplaced. The lack of effort on the part of health economists to look at equity more broadly than health care equity is concerning. Certainly, to be pursued in practice, equity in both health and health care need a shift in resources, which will be opposed by those who exercise power over decision making in health care and in society more generally. Currently health economists' analyses say all too little about power and property rights in health care and in society. It is argued that the relevant citizens or communities which a health service serves are best placed to judge the access barriers they face and their relative heights. A useful definition of equity established by a citizens' jury in Perth, Australia is used to exemplify this point. It is concluded that the often all too simplistic equity goals adopted in health economics (and sometimes public health discourse) need to be challenged. For health economists, there is a need for more of us to get involved in the issues around inequalities, class and power and the impact of these on health.

Mesh:

Year:  2009        PMID: 19192324     DOI: 10.1017/S1744133109004848

Source DB:  PubMed          Journal:  Health Econ Policy Law        ISSN: 1744-1331


  6 in total

1.  Amputation trends for patients with lower extremity ulcers due to diabetes and peripheral artery disease using statewide data.

Authors:  Misty D Humphries; Ann Brunson; Chin-Shang Li; Joy Melnikow; Patrick S Romano
Journal:  J Vasc Surg       Date:  2016-09-23       Impact factor: 4.268

2.  Determining Value in Health Technology Assessment: Stay the Course or Tack Away?

Authors:  J Jaime Caro; John E Brazier; Jonathan Karnon; Peter Kolominsky-Rabas; Alistair J McGuire; Erik Nord; Michael Schlander
Journal:  Pharmacoeconomics       Date:  2019-03       Impact factor: 4.981

3.  Access to the COVID-19 Vaccine.

Authors:  Dimitris Zavras
Journal:  Int J Environ Res Public Health       Date:  2022-09-03       Impact factor: 4.614

4.  Inequities in access to healthcare: analysis of national survey data across six Asia-Pacific countries.

Authors:  Samantha B Meyer; Tini C N Luong; Loreen Mamerow; Paul R Ward
Journal:  BMC Health Serv Res       Date:  2013-07-01       Impact factor: 2.655

5.  Access to antiretroviral therapy among HIV/AIDS patients in Chiang Mai province, Thailand.

Authors:  Woraluck Himakalasa; Siriwan Grisurapong; Sasipen Phuangsaichai
Journal:  HIV AIDS (Auckl)       Date:  2013-08-21

6.  Equity of access to primary healthcare for vulnerable populations: the IMPACT international online survey of innovations.

Authors:  Lauralie Richard; John Furler; Konstancja Densley; Jeannie Haggerty; Grant Russell; Jean-Frederic Levesque; Jane Gunn
Journal:  Int J Equity Health       Date:  2016-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.